ARTICLE | Clinical News
AAV2-hRPE65v2: Phase III data
October 12, 2015 7:00 AM UTC
Top-line data from an open-label, U.S. Phase III trial in 31 patients with inherited retinal dystrophies due to confirmed RPE65 gene mutations showed that SPK-RPE65 met the primary endpoint of improvi...